Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies

Mei Li, Jianing Ni, Lian Zhang, Can Chen, Jingjing Ye, Ninggang Chen

Open source

DOI
10.1080/14740338.2026.2701664
Published
2026-07-16
Container
Expert Opinion on Drug Safety
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14740338.2026.2701664,
  title = {Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies},
  author = {Mei Li and Jianing Ni and Lian Zhang and Can Chen and Jingjing Ye and Ninggang Chen},
  year = {2026},
  journal = {Expert Opinion on Drug Safety},
  doi = {10.1080/14740338.2026.2701664},
  url = {https://doi.org/10.1080/14740338.2026.2701664}
}

RIS

TY  - JOUR
TI  - Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies
AU  - Mei Li
AU  - Jianing Ni
AU  - Lian Zhang
AU  - Can Chen
AU  - Jingjing Ye
AU  - Ninggang Chen
PY  - 2026
JO  - Expert Opinion on Drug Safety
DO  - 10.1080/14740338.2026.2701664
UR  - https://doi.org/10.1080/14740338.2026.2701664
ER  - 

APA

Li, M., Ni, J., Zhang, L., Chen, C., Ye, J., & Chen, N. (2026). Safety of Janus kinase inhibitors in patients with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis of observational studies. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2026.2701664

Source records